CRVO News and Press, CervoMed Inc.

Interim biomarker data accepted for presentation at the 19 th Clinical Trials on Alzheimer's Disease (CTAD) conference Recent peer-reviewed data published in Nature Neuroscience demonstrate relevance of p38α as a therapeutic target and support neflamapimod's potential to treat f...

Latest findings on neflamapimod to be featured in presentations demonstrating its impact on dementia with Lewy bodies (DLB) disease progression, biomarkers of neurodegeneration, and basal forebrain atrophy, as well as optimal dosing strategies CervoMed’s science to be featured in five ...

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced the closing of its previously announced registered direct offering priced at-the-market u...

BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that it has entered into definitive agreements for the purchase and sale of 2,500,000 sha...

2026-06-18 10:29:28 ET DENVER, Colo. ( 247marketnews.com ) --The healthcare and biotechnology sector continues to generate a steady stream of meaningful catalysts as companies advance novel therapies, secure regulatory milestones, strengthen intellectual property portfolios, and expand ...

A look at the top 10 most actives in the United States Aditxt Inc. (ADTX) rose 193.2% to $0.0129 on volume of 2,879,564,739 shares GD Culture Group Limited (GDC) fell 0.5% to $0.021201 on volume of 371,791,086 shares Hyperscale Data Inc. (GPUS) rose 32.3% to $0.5265 on volume of 183,898,716...

BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that it has received a notice of allowance from the United States Patent and Trademark Of...

A look at the top 10 most actives in the United States Aditxt Inc. (ADTX) fell 15.5% to $0.0109 on volume of 800,333,930 shares GD Culture Group Limited (GDC) fell 73.3% to $0.0281 on volume of 682,648,326 shares Direxion Daily Semiconductor Bear 3X (SOXS) rose 17.2% to $4.63 on volume of 6...

2026-06-16 15:04:02 ET DENVER, Colo., ( 247marketnews.com ) – Clinical milestones, regulatory progress, insider buying, and newly public biotechnology platforms are among the leading themes for today’s power hour. CervoMed Gains Attention Neurodegenerative Pipeline...

2026-06-16 10:22:16 ET DENVER, Colo., ( 247marketnews.com ) – Multiple clinical-stage companies are delivered meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiov...